Doctors serving as paid consultants for the drug industry dominate required continuing medical education meetings. Pharma-conflicted physicians also populate committees that define “standard of care.” Drug companies fund the majority of studies that investigate the potential for statins to help or harm. Many of these studies do not present raw data and only show highly manipulated statistics, so we’re pretty much forced to take their word about the results. |